RQA 2025 International Conference
We are delighted to once again be a Silver Sponsor...
The Helsinki Declaration 2024 Update: Advancing Ethical Standards in the Era of Digital Clinical Research
The 2024 update offers important clarifications for pharmaceutical sponsors, clinical...
The Evolving Landscape of Pharmacovigilance IT: Key Considerations for the EU Regulation Amendment
The European Commission’s draft amendment to Implementing Regulation (EU) No...
Advancing Pharmaceutical Protocols: How ICH M11 CeSHarP Transforms Digital Compliance
The pharmaceutical industry is undergoing a significant transformation with the...
Matt Jones appointed Chair of the RQA Board of Directors
We are delighted to announce that Matt Jones has been...
The New Imperative: IT Supplier Quality Assurance Under ICH E6(R3)
As the July 2025 implementation date for ICH E6(R3) approaches,...